aluates Reports

$ 0.0

Automative

Global Prostate Cancer Hormone Therapy Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-23X12723

Global Prostate Cancer Hormone Therapy Market Research Report 2023

BUY CHAPTERS

Global Prostate Cancer Hormone Therapy Market Research Report 2025

Code: QYRE-Auto-23X12723

Report

May 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Astellas

Johnson & Johnson

Astrazeneca plc

Bayer

Merck

Tolmar

Zoladex

Ferring Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals

CTTQ

Prostate Cancer Hormone Therapy Market Size

The global market for Prostate Cancer Hormone Therapy was valued at US$ 12920 million in the year 2024 and is projected to reach a revised size of US$ 21560 million by 2031, growing at a CAGR of 7.7% during the forecast period.

Prostate Cancer Hormone Therapy Market

Hormone therapy for prostate cancer is a treatment that stops the hormone testosterone either from being made or from reaching prostate cancer cells. Most prostate cancer cells rely on testosterone to grow. Hormone therapy causes prostate cancer cells to die or to grow more slowly.

The prostate cancer hormone therapy market is evolving rapidly, driven by factors like:

Rising prostate cancer diagnosis: Prostate cancer remains the most common cancer among men in many countries. Early diagnosis and improved treatment options have contributed to increasing survival rates, fueling market growth.

Shifting treatment trends: Hormone therapy, which aims to lower testosterone levels and starve prostate cancer cells, is a cornerstone treatment for advanced and recurrent prostate cancer. Advancements in medication and targeted therapies are shaping the market landscape.

Personalized medicine: Growing understanding of cancer genomics and individual variations in response to therapy is leading to the development of personalized treatment plans, including targeted hormone therapies with fewer side effects.

Drug landscape: A variety of drugs belonging to different classes, like GnRH agonists, antagonists, and androgen receptor inhibitors, cater to diverse patient needs and treatment stages.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Hormone Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Hormone Therapy.

The Prostate Cancer Hormone Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Hormone Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Hormone Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prostate Cancer Hormone Therapy Market Report

Report Metric	Details
Report Name	Prostate Cancer Hormone Therapy Market
Accounted market size in year	US$ 12920 million
Forecasted market size in 2031	US$ 21560 million
CAGR	7.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Tablet Injection
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Astellas, Johnson & Johnson, AstraZeneca, Bayer, Merck, Tolmar, Zoladex, Ferring Pharmaceuticals, Jiangsu Hengrui Pharmaceuticals, CTTQ
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Hormone Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Prostate Cancer Hormone Therapy Market growing?

Ans: The Prostate Cancer Hormone Therapy Market witnessing a CAGR of 7.7% during the forecast period 2025-2031.

What is the Prostate Cancer Hormone Therapy Market size in 2031?

Ans: The Prostate Cancer Hormone Therapy Market size in 2031 will be US$ 21560 million.

Who are the main players in the Prostate Cancer Hormone Therapy Market report?

Ans: The main players in the Prostate Cancer Hormone Therapy Market are Pfizer, Astellas, Johnson & Johnson, AstraZeneca, Bayer, Merck, Tolmar, Zoladex, Ferring Pharmaceuticals, Jiangsu Hengrui Pharmaceuticals, CTTQ

What are the Application segmentation covered in the Prostate Cancer Hormone Therapy Market report?

Ans: The Applications covered in the Prostate Cancer Hormone Therapy Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Prostate Cancer Hormone Therapy Market report?

Ans: The Types covered in the Prostate Cancer Hormone Therapy Market report are Tablet, Injection

Recommended Reports

Prostate & Urological Cancer

Hormonal Therapy Markets

Oncology Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Hormone Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tablet

1.2.3 Injection

1.3 Market by Application

1.3.1 Global Prostate Cancer Hormone Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Hormone Therapy Market Perspective (2020-2031)

2.2 Global Prostate Cancer Hormone Therapy Growth Trends by Region

2.2.1 Global Prostate Cancer Hormone Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Prostate Cancer Hormone Therapy Historic Market Size by Region (2020-2025)

2.2.3 Prostate Cancer Hormone Therapy Forecasted Market Size by Region (2026-2031)

2.3 Prostate Cancer Hormone Therapy Market Dynamics

2.3.1 Prostate Cancer Hormone Therapy Industry Trends

2.3.2 Prostate Cancer Hormone Therapy Market Drivers

2.3.3 Prostate Cancer Hormone Therapy Market Challenges

2.3.4 Prostate Cancer Hormone Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Hormone Therapy Players by Revenue

3.1.1 Global Top Prostate Cancer Hormone Therapy Players by Revenue (2020-2025)

3.1.2 Global Prostate Cancer Hormone Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Prostate Cancer Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Prostate Cancer Hormone Therapy Revenue

3.4 Global Prostate Cancer Hormone Therapy Market Concentration Ratio

3.4.1 Global Prostate Cancer Hormone Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Hormone Therapy Revenue in 2024

3.5 Global Key Players of Prostate Cancer Hormone Therapy Head office and Area Served

3.6 Global Key Players of Prostate Cancer Hormone Therapy, Product and Application

3.7 Global Key Players of Prostate Cancer Hormone Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Hormone Therapy Breakdown Data by Type

4.1 Global Prostate Cancer Hormone Therapy Historic Market Size by Type (2020-2025)

4.2 Global Prostate Cancer Hormone Therapy Forecasted Market Size by Type (2026-2031)

5 Prostate Cancer Hormone Therapy Breakdown Data by Application

5.1 Global Prostate Cancer Hormone Therapy Historic Market Size by Application (2020-2025)

5.2 Global Prostate Cancer Hormone Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Prostate Cancer Hormone Therapy Market Size (2020-2031)

6.2 North America Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)

6.4 North America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Hormone Therapy Market Size (2020-2031)

7.2 Europe Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)

7.4 Europe Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Hormone Therapy Market Size (2020-2031)

8.2 Asia-Pacific Prostate Cancer Hormone Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate Cancer Hormone Therapy Market Size (2020-2031)

9.2 Latin America Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)

9.4 Latin America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Hormone Therapy Market Size (2020-2031)

10.2 Middle East & Africa Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Prostate Cancer Hormone Therapy Introduction

11.1.4 Pfizer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Astellas

11.2.1 Astellas Company Details

11.2.2 Astellas Business Overview

11.2.3 Astellas Prostate Cancer Hormone Therapy Introduction

11.2.4 Astellas Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.2.5 Astellas Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Prostate Cancer Hormone Therapy Introduction

11.3.4 Johnson & Johnson Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Details

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Prostate Cancer Hormone Therapy Introduction

11.4.4 AstraZeneca Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.4.5 AstraZeneca Recent Development

11.5 Bayer

11.5.1 Bayer Company Details

11.5.2 Bayer Business Overview

11.5.3 Bayer Prostate Cancer Hormone Therapy Introduction

11.5.4 Bayer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.5.5 Bayer Recent Development

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Prostate Cancer Hormone Therapy Introduction

11.6.4 Merck Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.6.5 Merck Recent Development

11.7 Tolmar

11.7.1 Tolmar Company Details

11.7.2 Tolmar Business Overview

11.7.3 Tolmar Prostate Cancer Hormone Therapy Introduction

11.7.4 Tolmar Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.7.5 Tolmar Recent Development

11.8 Zoladex

11.8.1 Zoladex Company Details

11.8.2 Zoladex Business Overview

11.8.3 Zoladex Prostate Cancer Hormone Therapy Introduction

11.8.4 Zoladex Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.8.5 Zoladex Recent Development

11.9 Ferring Pharmaceuticals

11.9.1 Ferring Pharmaceuticals Company Details

11.9.2 Ferring Pharmaceuticals Business Overview

11.9.3 Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Introduction

11.9.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.9.5 Ferring Pharmaceuticals Recent Development

11.10 Jiangsu Hengrui Pharmaceuticals

11.10.1 Jiangsu Hengrui Pharmaceuticals Company Details

11.10.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.10.3 Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Introduction

11.10.4 Jiangsu Hengrui Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.10.5 Jiangsu Hengrui Pharmaceuticals Recent Development

11.11 CTTQ

11.11.1 CTTQ Company Details

11.11.2 CTTQ Business Overview

11.11.3 CTTQ Prostate Cancer Hormone Therapy Introduction

11.11.4 CTTQ Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)

11.11.5 CTTQ Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Astellas

Johnson & Johnson

Astrazeneca plc

Bayer

Merck

Tolmar

Zoladex

Ferring Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals

CTTQ

List of Tables

Table 1. Global Prostate Cancer Hormone Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tablet

Table 3. Key Players of Injection

Table 4. Global Prostate Cancer Hormone Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Prostate Cancer Hormone Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Prostate Cancer Hormone Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Prostate Cancer Hormone Therapy Market Share by Region (2020-2025)

Table 8. Global Prostate Cancer Hormone Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Prostate Cancer Hormone Therapy Market Share by Region (2026-2031)

Table 10. Prostate Cancer Hormone Therapy Market Trends

Table 11. Prostate Cancer Hormone Therapy Market Drivers

Table 12. Prostate Cancer Hormone Therapy Market Challenges

Table 13. Prostate Cancer Hormone Therapy Market Restraints

Table 14. Global Prostate Cancer Hormone Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Prostate Cancer Hormone Therapy Market Share by Players (2020-2025)

Table 16. Global Top Prostate Cancer Hormone Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Hormone Therapy as of 2024)

Table 17. Ranking of Global Top Prostate Cancer Hormone Therapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Prostate Cancer Hormone Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Prostate Cancer Hormone Therapy, Headquarters and Area Served

Table 20. Global Key Players of Prostate Cancer Hormone Therapy, Product and Application

Table 21. Global Key Players of Prostate Cancer Hormone Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Prostate Cancer Hormone Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Prostate Cancer Hormone Therapy Revenue Market Share by Type (2020-2025)

Table 25. Global Prostate Cancer Hormone Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Prostate Cancer Hormone Therapy Revenue Market Share by Type (2026-2031)

Table 27. Global Prostate Cancer Hormone Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Prostate Cancer Hormone Therapy Revenue Market Share by Application (2020-2025)

Table 29. Global Prostate Cancer Hormone Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Prostate Cancer Hormone Therapy Revenue Market Share by Application (2026-2031)

Table 31. North America Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Prostate Cancer Hormone Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Prostate Cancer Hormone Therapy Product

Table 49. Pfizer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Astellas Company Details

Table 52. Astellas Business Overview

Table 53. Astellas Prostate Cancer Hormone Therapy Product

Table 54. Astellas Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 55. Astellas Recent Development

Table 56. Johnson & Johnson Company Details

Table 57. Johnson & Johnson Business Overview

Table 58. Johnson & Johnson Prostate Cancer Hormone Therapy Product

Table 59. Johnson & Johnson Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 60. Johnson & Johnson Recent Development

Table 61. AstraZeneca Company Details

Table 62. AstraZeneca Business Overview

Table 63. AstraZeneca Prostate Cancer Hormone Therapy Product

Table 64. AstraZeneca Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 65. AstraZeneca Recent Development

Table 66. Bayer Company Details

Table 67. Bayer Business Overview

Table 68. Bayer Prostate Cancer Hormone Therapy Product

Table 69. Bayer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 70. Bayer Recent Development

Table 71. Merck Company Details

Table 72. Merck Business Overview

Table 73. Merck Prostate Cancer Hormone Therapy Product

Table 74. Merck Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 75. Merck Recent Development

Table 76. Tolmar Company Details

Table 77. Tolmar Business Overview

Table 78. Tolmar Prostate Cancer Hormone Therapy Product

Table 79. Tolmar Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 80. Tolmar Recent Development

Table 81. Zoladex Company Details

Table 82. Zoladex Business Overview

Table 83. Zoladex Prostate Cancer Hormone Therapy Product

Table 84. Zoladex Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 85. Zoladex Recent Development

Table 86. Ferring Pharmaceuticals Company Details

Table 87. Ferring Pharmaceuticals Business Overview

Table 88. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Product

Table 89. Ferring Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 90. Ferring Pharmaceuticals Recent Development

Table 91. Jiangsu Hengrui Pharmaceuticals Company Details

Table 92. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 93. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Product

Table 94. Jiangsu Hengrui Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 95. Jiangsu Hengrui Pharmaceuticals Recent Development

Table 96. CTTQ Company Details

Table 97. CTTQ Business Overview

Table 98. CTTQ Prostate Cancer Hormone Therapy Product

Table 99. CTTQ Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)

Table 100. CTTQ Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Prostate Cancer Hormone Therapy Picture

Figure 2. Global Prostate Cancer Hormone Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Prostate Cancer Hormone Therapy Market Share by Type: 2024 VS 2031

Figure 4. Tablet Features

Figure 5. Injection Features

Figure 6. Global Prostate Cancer Hormone Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Prostate Cancer Hormone Therapy Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Prostate Cancer Hormone Therapy Report Years Considered

Figure 12. Global Prostate Cancer Hormone Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Prostate Cancer Hormone Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Prostate Cancer Hormone Therapy Market Share by Region: 2024 VS 2031

Figure 15. Global Prostate Cancer Hormone Therapy Market Share by Players in 2024

Figure 16. Global Top Prostate Cancer Hormone Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Hormone Therapy as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Hormone Therapy Revenue in 2024

Figure 18. North America Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)

Figure 20. United States Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)

Figure 24. Germany Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Prostate Cancer Hormone Therapy Market Share by Region (2020-2031)

Figure 32. China Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)

Figure 40. Mexico Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)

Figure 44. Turkey Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 48. Astellas Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 49. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 50. AstraZeneca Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 51. Bayer Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 53. Tolmar Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 54. Zoladex Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 55. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 56. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 57. CTTQ Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Breast Cancer Hormone Therapy Market Insights Forecast to 2030

Hormone Replacement Therapy HRT Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Androgen Suppression Therapy Market Insights Forecast to 2030

Global Hormone Replacement Therapy Market Insights Forecast to 2030

Global Antihormonal Cancer Therapies Market Insights Forecast to 2030

Global Endocrine Therapy Medication Market Research Report 2024

Hormone Replacement Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Treatment Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hormone Sensitive Prostate Cancer Drugs Market Research Report 2024

Global Hormone Pellet Therapy Market Research Report 2024

Global Androgen Deprivation Therapy ADT Market Insights Forecast to 2030

Testosterone Hormone Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs For Hormonal Replacement Market Insights Forecast to 2030

Global Hormone Releasing Agonists Market Research Report 2024

Endocrine Therapy Drugs ETDs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Medicine Market Insights Forecast to 2030

Global Testosterone Replacement Therapy Market Insights Forecast to 2030

Global Prostate Cancer Devices Market Research Report 2025

Hormone Replacement Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions